Company Legal Name
Latest Valuation
Founded Year
Headquarter
Abridge AI, Inc. develops artificial intelligence-powered medical scribe software that automatically generates clinical documentation from patient-provider conversations, with seamless integration into Epic electronic health records systems. Founded in 2018 and headquartered in Pittsburgh, the company addresses the critical healthcare challenge of physician burnout and administrative burden through advanced natural language processing technology. Abridge has achieved significant market recognition, securing a $2.75 billion valuation as healthcare systems increasingly adopt AI solutions to improve clinical workflow efficiency. The company continues expanding its AI capabilities and healthcare system partnerships to transform medical documentation processes across the industry.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.





